Search

everythinglearnresearchcommunity

for

Search:↓

Old age, male sex, smoking, and obesity may affect COVID-19 severity, but more research is needed.

Good nutrition and essential trace elements like zinc, selenium, and iron are important for a strong immune system and reducing COVID-19 severity.

COVID-19 vaccination may lower vitamin D levels and cause hair loss.

COVID-19 can increase the risk of hair loss, especially in people over 40.

Stress and COVID-19 can worsen hair loss conditions like alopecia areata.

Genetic differences affect COVID-19 severity and treatment development.

COVID-19 vaccines have been linked to an increase in hair loss conditions.

Telogen effluvium is common after symptomatic COVID-19, especially in young females, and may be linked to nutritional deficiencies.

The COVID-19 pandemic changed the types of skin conditions seen at a clinic, with fewer patients and varying numbers of specific conditions.

COVID-19 vaccines can trigger autoimmune flares but are still beneficial for patients with autoimmune conditions.

The COVID-19 pandemic led to fewer dermatology visits and changed the types of skin conditions patients experienced.

COVID-19 generally causes fewer complications than influenza, except for certain conditions like hair loss and heart issues.

Possible link between androgens and COVID-19 severity; more research needed.

Hair loss reduces hair thickness and coverage, but drug treatments mainly revive dormant hairs rather than reverse thinning; patients often undervalue their hair loss severity.

People with androgenetic alopecia had milder COVID-19 symptoms during the Omicron wave in China.

COVID-19 may cause common hair loss due to stress, immune response, medications, and other health issues.

There have been major advances in diagnosing and treating hair loss over the last 30 years, with new drugs and improved hair transplant techniques.

Some people who recover from COVID-19 continue to have symptoms like fatigue and cough for over 120 days, and some experience hair loss about 59 days after getting sick.

Mesenchymal stromal cells may help treat severe COVID-19, but more research is needed to confirm their effectiveness.

COVID-19 can cause various skin issues, including rashes and 'COVID toes', and may worsen autoimmune diseases or affect men with baldness more severely.

COVID-19-related hair loss may be linked to blood flow disorders and inflammation.

Recent research on androgenetic alopecia focuses on optimizing treatments, with promising new therapies emerging.

COVID-19 vaccination may slightly increase the risk of hair loss, but benefits outweigh this risk.

Combining PEMF with PBST is more effective for hair regrowth than PBST alone.

Most women aged 20-40 in the study lost hair diffusely and in volume over 6 weeks to 6 months, mainly due to telogen effluvium, often without a clear cause.

The described COVID-19 treatments seemed effective in influencing the disease's course, duration, and severity.

The role of antibodies in alopecia is unclear, but JAK inhibitors show promise for treatment.

The article suggests using safety measures and telemedicine for aesthetic dermatology during COVID-19, while some procedures can still be done safely.

Dermatologists helped identify COVID-19 through skin symptoms and managed skin issues during the pandemic, but more high-quality research is needed.

Patients with chronic skin conditions on systemic treatments did not have worse COVID-19 outcomes and could resume their treatments after recovery.